Prenuvo, a medical imaging company specializing in early disease detection, has raised $70 million in series A fundraising and debt financing.
The company plans to use the funding to expand its artificial intelligence team and for national expansion of its radiation-free full body scan technology. Prenuvo has grown 240 percent year over year, according to the Oct. 18 Prenuvo news release provided to Becker's.
"The current healthcare system is reactive. For many, health information comes too late, once a disease or condition has progressed, has symptoms, and is more difficult and expensive to treat," Prenuvo founder and CEO Andrew Lacy said. "Our series A financing is validation of Prenuvo's mission to catch conditions before they become crises and transform the healthcare approach as we know it to one that is rooted in proactive health."